Skip to content

Clinical trials

Conversion Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Conversion Disorder Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20073
20081
20091
20143
20151
20163
20172
20182
20193
20202
20217
202217
20239
20248
202510
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Unknown status16
Recruiting14
Not yet recruiting12
Active, not recruiting4
Terminated2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
King's College London5
Medical University of Graz4
National Institute of Neurological Disorders and Stroke (NINDS)4
Western University, Canada4
Centre Hospitalier Universitaire de Nīmes3
Rhode Island Hospital3
University College, London3
University of Edinburgh3
University of Fribourg3
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Conversion Disorder89
Seizures11
Psychogenic Nonepileptic Seizures9
Parkinson Disease5
Multiple Sclerosis4
Dissociative Disorders3
Movement Disorders3
Pain3
Paralysis3
Stress Disorders, Post-Traumatic3

Trials

Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.